Vaccinated and convalescent donor-derived SARS-CoV-2-specific T cells as adoptive immunotherapy for high-risk COVID-19 patients
暂无分享，去创建一个
G. Karavalakis | A. Georgakopoulou | E. Yannaki | A. Anagnostopoulos | P. Papayanni | E. Gavriilaki | I. Kioumis | A. Boutou | A. Fylaktou | A. Papadopoulou | D. Chloros | P. Tasioudis | E. Geka | M. Bitzani | M. Triantafyllidou | E. Siotou | K. Koukoulias | Sotiria Dimou‐Besikli | C. Giannaki | Dimitrios Chasiotis | A. Iatrou